2021
DOI: 10.1039/d1ay01654g
|View full text |Cite
|
Sign up to set email alerts
|

A direct competitive nanozyme-linked immunosorbent assay based on MnO2 nanosheets as a catalytic label for the determination of fumonisin B1

Abstract: A direct competitive nanozyme-linked immunosorbent assay (dcNLISA) based on MnO2 nanosheets (MnO2 NSs) as a nanozyme label was developed for the highly sensitive determination of fumonisin B1 (FB1).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…29 Cai et al developed a direct competitive nano-enzyme-linked immunosorbent assay for the determination of FB 1 with an LOD of 0.63 ng mL −1 . 30 Although the LOD of this method is not comparable to the above methods, it meets the requirements of the EU and FDA, and the method has a wide detectable range of FB 1 , short detection time and low detection cost.…”
Section: Resultsmentioning
confidence: 92%
“…29 Cai et al developed a direct competitive nano-enzyme-linked immunosorbent assay for the determination of FB 1 with an LOD of 0.63 ng mL −1 . 30 Although the LOD of this method is not comparable to the above methods, it meets the requirements of the EU and FDA, and the method has a wide detectable range of FB 1 , short detection time and low detection cost.…”
Section: Resultsmentioning
confidence: 92%
“…Additionally, the unique catalytic properties of nanozymes can result in reduced background noise and improved signal-to-noise ratios, enhancing the assay's specificity. 83 The flexibility to choose from various detection methods adds versatility to NLISA, making it adaptable to different experimental setups and sample types. 84,85 For instance, Li et al devised an innovative method named the nanozyme-linked immunosorbent surface plasmon resonance (nano-ELISPR) biosensor, designed for highly sensitive cancer biomarker detection.…”
Section: Analyte/target Selectivitymentioning
confidence: 99%